Dear Doctor - Participate in the Survey on thromboprophylaxis " A recent survey of patients with thrombophilia found that most patients are not receiving adequate thromboprophylaxis. Thrombophilia is a condition that predisposes patients to developing blood clots, and thromboprophylaxis is the use of medication or other interventions to prevent blood clots from forming.The survey found that only 43% of patients with thrombophilia were receiving anticoagulant medication, which is the most effective form of thromboprophylaxis. This means that the majority of patients with thrombophilia are not being adequately protected from developing blood clots.There are several reasons why patients with thrombophilia may not be receiving appropriate thromboprophylaxis. First, many patients are not aware that they have thrombophilia. Second, even when patients are aware of their condition, they may not be aware of the importance of using anticoagulants or other forms of thromboprophylaxis. Third, some patients may be reluctant to take anticoagulants because of the potential side effects. Finally, some physicians may not be familiar with the latest guidelines for managing thrombophilia and therefore may not be prescribing anticoagulants to their patients with this condition.The results of this survey underscore the need for better education for both patients and physicians about thrombophilia . Participate in Surveys "
1.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
2.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
3.
Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL
4.
Team finds broken 'brake' on cancer mutation machine.
5.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
1.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
2.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
3.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
4.
Future of Oncology: Targeted Therapies & Collaborative Innovation Shaping Cancer Care in the USA
5.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation